• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Jim Cramer

Jim Cramer: The HQ for Innovation Is Right Here in San Francisco

The NYSE used to be the center of capitalism, but now it's where actual engineering, not financial engineering, is taking place.
By JIM CRAMER Jan 13, 2020 | 04:41 PM EST
Stocks quotes in this article: BA, JPM, BMY, GSX, CVS, WBA, GWPH, CGC, STZ, AAPL, CRWD, ZS, PANW, GOOGL, AMZN, FB

Innovation is the lifeblood of capitalism. For the longest time, the headquarters for capitalism was where Wall Street hit Broad Street -- that's right, the New York Stock Exchange, and all of its accouterments, the banks, the brokerages and the money.

But that's no longer the case. The headquarters for innovation is right here in San Francisco, and on a day where the averages rolled higher with the Nasdaq as leader, we come out to cheer capitalism's new headquarters, because actual engineering, not financial engineering, is what matters.

Capitalism's under assault right now, taking its lumps here in ways not seen since the Great Depression. The problem? Wage disparity -- and it is something that I know is universal, and, frankly in your face, like the $62 million that Boeing (BA) was contractually obligated to pay ex-CEO Dennis Muilenberg, fired for inability to get the MAX problem fixed in the wake of two air tragedies.

Can new CEO David Calhoun change the trajectory, as well as a culture that seems rotten in light of some suboptimal emails and stands like no new training is needed for the MAX, something that's fine if you have flown thousands of hours like U.S. pilots, but not fine when your clients are foreign countries with different standards, standards that needed to be augmented if they were going to understand all the new systems. Except Muilenberg contended they weren't new and he's been broomed for that and a host of other reasons. You can be sure that negative light shone on capitalism will be mentioned repeatedly on the campaign trail.

I think capitalism deserves a better shake and that belief stems from what's happening out here in San Francisco. Now, we've got a real windfall here: JP Morgan (JPM) is host for one of the largest conferences in the world, the JP Morgan Healthcare conference, and we are out here to explore all of the new drugs and devices that are real bargains if you need them.

Every year there is a theme to this conference, and this year it is personalization in health care, a system that increasingly runs on the customer's choice, if the customer will accept it. We have been hearing a lot from Democratic front runner U.S. Sen. Bernie Sanders that the government should be paying for your health care and that the system as it is now produces tremendous inequities. That's undeniable.

To listen to him is to believe that every company out here is a ripoff.

But I am not here to bash; I am here to shine a light on what's changing things and what's being rewarded financially for changing them.

First, we recently heard about a dramatic decline in cancer deaths, a drop-off that can only be explained by what's going on out here.

Bristol-Myers Squibb (BMY) , for example, has the best oncological franchise there is, now that it has merged with Celgene, a deal announced last year that is already paying dividends, and I don't mean the bountiful ones it pays to shareholders. Opdivo and Yervoy and now Revlimid are all being experimented with for so many different cancers. When we met this morning with Bristol CEO Giovanni Caforio, he talked about drug price restraint. I think the restraint is real and the life-saving priceless.

Or how about how about what Emma Walmsley and GlaxoSmithKline (GSX) are doing for the advancement of early care for still too common ovarian cancer. Talk about consumer choice, she's teaming with genomics and biotech firm 23andMe to find out who might be most susceptible to cancer for early detection. Sometimes it is only awareness that keeps the innovation from the hands of the people. Then there are vaccines. SmithKline has invented a vaccine for shingles, one of the most painful illnesses that a third of the people in the United States will get. It doesn't have to happen. You get the vaccine, you don't get the illness.

And then there is CVS Health (CVS) . Here's a company that's changing the paradigm. No longer wanting to be pegged as a corner drug store, CVS has stepped in to the consumerization of health care in a big way. With its Health Hubs -- now just a small but successful trial, but soon to be in 1,500 stores -- CVS is helping the customer with health care the way a doctor formerly helped. If you have a practitioner that might not be a big deal. But most millennials and Gen Xers don't. They go to the emergency room when they need help. CVS might be the answer to that breakdown in the health care system and now that it has merged with insurer Aetna, it can help 50 million boomers figure out what to do with all the forms of Medicare insurance.

Remember when CVS was supposed to be Amazon roadkill, both the front and the back? Remember when Walgreen's (WBA) was going to take all its business when the Theranos machine test began in Arizona? Remember when CVS had to take the billion dollar tobacco hit when CEO Larry Merlo, who will be with us soon, said what of company can pretend to be a health care company if it is a purveyor of cigarettes?

Or how about GW Pharma (GWPH) ? We've pretty much given up on the idea that cannabis can make a dent in the U.S. health care system. And then we got the preannouncement yesterday from GW Pharma that it had a $100 million-plus quarter. GW Pharma makes Epidiolex, a legal form of a cannabis treatment -- made of cannabidiol -- that's made for children who have epilepsy. It's speaking at the conference about how the dreadful illness' treatment -- which ignited the entire group of pot stocks. We haven't liked them, but we sure like what we heard about Canopy Growth (CGC) from Bill Newlands, the CEO of Constellation Brands (STZ) , which just put its fantastic CFO, David Klein, at the helm of Canopy, which has the capability to control national legalization.

I say be careful, I don't see legalization any time soon, and that's why GW Pharma's treatment is able to outsell pretty much the entire industry.

Of course the rally, especially in the Nasdaq wasn't just in the health care sector. The 5G story we keep flogging worked again with Apple (AAPL) leading the way followed by a host of semiconductors and Monday the tower stocks rallied. I keep telling you that 5G is a huge theme.

Cybersecurity stocks erupted as we heard rumors that the U.S. was about to launch a cyber attack on Iranian infrastructure. That would certainly require mandatory cyber protection, so we saw the stocks of Crowdstrike Holdings (CRWD) , Zscaler (ZS) and Palo Alto (PANW) surge.

Plus, it is worth noting that Alphabet (GOOGL) is nearing trillion dollar status. I don't like that this move is based on nothing fundamental, just the momentum that we see in so many techs. Momentum that we see in the two other stocks in the trillion dollar club: Amazon (AMZN) and Apple, something that can't withstand anything but super beats, not just better than expected by a couple of pennies. I don't know if that's even possible. Facebook's (FB) in the same boat.

Innovation drives capitalism and capitalism drives innovation; you can't have one without the other, at least if you are going to have the kind of wonderment I have now seen.

(AMZN, AAPL, BMY, CVS, GOOGL,FB, JPM are holdings in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells them? Learn more now.)
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
TAGS: Health Insurance | Distress Indicator | Stocks | Aerospace | Financial Services | Health Care Equipment & Services | Healthcare | Jim Cramer | Health | Stock of the Day |

More from Jim Cramer

Jim Cramer: I'll Put My Money With 'Boring but Lucrative' Any Day

Jim Cramer
Sep 29, 2021 1:28 PM EDT

Let's look at that recent downgrade of 'dull' Morgan Stanley and see why exciting is best left for the stadiums and amusement parks -- and not stocks.

Jim Cramer: America's Toughest Job? Finding Workers

Jim Cramer
Sep 28, 2021 12:17 PM EDT

It's the question of our time: Where are the people willing to take on these better paying gigs? Let's see what's going on and what we need to happen.

Jim Cramer: Here's How Analysts Can Be Off By a Wide Margin

Jim Cramer
Sep 24, 2021 12:02 PM EDT

Let's look at the reactions to Nike, Costco and Salesforce to see what happens when they're viewed from a real world perspective.

Jim Cramer: It's Pure Insanity That We Don't Make Chips Here in the U.S.

Jim Cramer
Sep 23, 2021 11:05 AM EDT

While the big guns meet at the White House about the global chip shortage, the president and these companies are approaching this all wrong.

Jim Cramer: Go Ahead, Have a Cow, but I Say Powell and Xi Are Bulls

Jim Cramer
Sep 22, 2021 3:51 PM EDT

We rallied, because China's President Xi and Fed Chair Powell made decisions that they knew would lead to rallies.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:27 PM EST REAL MONEY

    LIVE EVENT: Chris Versace and "Sarge" Guilfoyle Share Their Stock Market Insights

    This Monday, Jan. 30, at 12 p.m., our very own exp...
  • 11:48 AM EST REAL MONEY

    Watch Doug Kass on the Daily Rundown!

    In today's Action Alerts PLUS Daily Rundown, Doug ...
  • 11:03 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend On Real Money

    It's time to start using this power to build great...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login